Stock

Kwality Pharmaceuticals — MTF Book

KPL · Kwality Pharmaceuticals Limited
Health Technology

Daily Margin Trading Facility book for Kwality Pharmaceuticals across NSE and BSE, from 11 Aug 2026. All figures in ₹ crore, derived from exchange public disclosures.

What is Kwality Pharmaceuticals’s MTF book?

Kwality Pharmaceuticals Limited (KPL) has ₹24 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.02% of India’s MTF book, ranking #949. Over 1M (the last 30 trading days) the funded value has fallen 19.9%, with the number of shares under margin down 22.5%.

Funded value
₹24 Cr
as of 23 Oct 2026
Rank in book
#949
49 days tracked
Share of book
0.02%
of the whole NSE + BSE book
Peak funded
₹31 Cr
on 10 Sep 2026
Largest single-day addition
+₹4 Cr
on 08 Sep 2026
Largest single-day unwind
−₹3 Cr
on 16 Sep 2026
Market cap
₹3,661 Cr
Small cap · free float not yet filed
MTF share of free float
—
needs a free-float filing

Dated events

NSE & BSE split

How KPL’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹23 Cr · 94.6%BSE ₹1 Cr · 5.4%

MTF vs Price

Margin-funded outstanding for KPL in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where KPL has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

KPL — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 202624+₹00.02%949
22 Oct 202624+₹00.02%966
21 Oct 202624+₹00.01%975
16 Oct 202624+₹10.01%991
15 Oct 202623−₹00.01%997
14 Oct 202623+₹00.01%992
13 Oct 202623+₹00.01%994
12 Oct 202623−₹00.01%994
09 Oct 202623−₹00.01%991
08 Oct 202623−₹10.01%988
07 Oct 202623+₹10.01%981
06 Oct 202623−₹00.01%985
05 Oct 202623+₹00.01%975
01 Oct 202623−₹00.01%992
30 Sep 202623+₹00.01%988
29 Sep 202623−₹00.01%992
28 Sep 202623+₹00.01%981
25 Sep 202623+₹00.01%986
24 Sep 202623+₹00.01%987
23 Sep 202623−₹00.01%994
22 Sep 202623+₹00.01%990
18 Sep 202623−₹10.01%983
17 Sep 202624−₹00.01%962
16 Sep 202624−₹30.02%954
15 Sep 202628−₹20.02%908
11 Sep 202629−₹20.02%887
10 Sep 202631+₹00.02%857
09 Sep 202631+₹10.02%858
08 Sep 202630+₹40.02%868
07 Sep 202627—0.02%921

KPL within Health Technology

Ranked #59 of 61 funded Health Technology stocks, carrying 0.4% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
57FDCFDC Limited₹260.4%1.27%−16.4%
58FREDUNFredun Pharmaceuticals₹250.4%——
59KPLKwality Pharmaceuticals₹240.4%—−19.9%
60ERISEris Lifesciences₹240.4%0.28%—
61SETLStandard Engineering Technology₹230.3%0.90%—

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.